Resoconti I-Mab BOERSE MUENCHEN

Azioni

Mercato chiuso - BOERSE MUENCHEN Altri mercati azionari 21:43:15 21/06/2024			Variaz. 5gg	Var. 1 gen.
1,59 ^EUR	0,00%		-7,56%	-4,79%

06/06	I-Mab nomina Phillip Dennis come Chief Medical Officer	CI
05/06	I-Mab collabora con Bristol-Myers per valutare Givastomig nello studio di combinazione per i tumori gastrici ed esofagei	MT

Transcript : I-Mab, H1 2023 Earnings Call, Aug 17, 2023	17/08/23
Transcript : I-Mab, 2022 Earnings Call, Mar 31, 2023	31/03/23
Transcript : I-Mab - Shareholder/Analyst Call	12/09/22
Transcript : I-Mab, H1 2022 Earnings Call, Aug 30, 2022	30/08/22
Transcript : I-Mab - Special Call	20/07/22
Transcript : I-Mab - Special Call	27/05/22
Transcript : I-Mab, 2021 Earnings Call, Mar 29, 2022	29/03/22
Transcript : I-Mab Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 04:30 PM	11/01/22
Transcript : I-Mab - Special Call	21/12/21
Transcript : I-Mab - Special Call	14/12/21
Transcript : I-Mab, H1 2021 Earnings Call, Aug 31, 2021	31/08/21
Transcript : I-Mab - Special Call	07/06/21
Transcript : I-Mab Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-01-2021 03:00 PM	01/06/21
Transcript : I-Mab - Special Call	26/04/21
Transcript : I-Mab, 2020 Earnings Call, Mar 29, 2021	29/03/21
Transcript : I-Mab - Special Call	13/11/20
Transcript : I-Mab Presents at SITC Annual Meeting 2020, Nov-09-2020 08:30 AM	09/11/20
Transcript : I-Mab - Shareholder/Analyst Call	04/09/20
Transcript : I-Mab, H1 2020 Earnings Call, Aug 31, 2020	31/08/20
Transcript : I-Mab - Special Call	28/05/20

Non ci sono risultati per questa ricerca